INSIGHTS ON PHARMACEUTICAL PACKAGING

• Autoinjectors For Autoimmune Diseases: Benefits And Considerations

  By improving convenience, ensuring precise dosing, and reducing dependency on healthcare facilities, autoinjectors enhance patient outcomes and quality of life.

• Material Transfer Into A Cleanroom: How To Reduce Contamination Risk At Every Step

  Evaluate packaging integrity and master wiping techniques to prevent cleanroom contamination. Focus on surface coverage and controlled transfer paths to ensure consistent product safety and quality.

• Commercializing Innovation

  Explore how packaging safeguards life science products and why innovation cultures matter. Oliver Stauffer offers grounded insights on turning scientific advances into sustainable, real-world impact.

• Helium Leak Detection On Glass Cartridge Containers

  Helium leak detection offers unmatched sensitivity for verifying glass cartridge seal integrity. Learn how this advanced method outperforms traditional tests and provides confidence in packaging.

• Nutraceutical Packaging Inspection: Challenges, Technologies, And Solutions For Supplement Manufacturers

  7/24/2026

  Advanced X-ray inspection, metal detection, and checkweighing technologies ensure fill accuracy, eliminate contaminants, and protect nutraceutical brands.

• 3D Screen Printing: Enabling A New Generation Of Complex Formulations

  3/17/2025

  Screen-Printed Innovative Drug Technology can produce oral, transdermal, and implantable dosage forms while ensuring heterogeneous distribution of active ingredients.

• Ophthalmic Drug Delivery: Meeting Modern Challenges With A Next Generation Solution

  8/17/2026

  Ophthalmic injectable packaging demands early strategic attention. Learn how silicone oil contamination, particulate limits, and dosing accuracy challenges can derail development programs and what it takes to stay compliant.

• Determining The Limit Of Detection In CCIT

  12/18/2025

  Accurately determining the smallest detectable defect in pharmaceutical packaging is essential for sterility. Learn how test sensitivity, positive controls, and regulatory standards shape CCI strategies.

• De-Risking The Transition From Vial To Drug-Device Combination Product

  7/25/2025

  When transitioning from a vial to a combination product system, the best approach is to have a holistic de-risk strategy with an intentional focus on the patient, the plan, and the product.